Paris, France – June 13, 2018 – Sanofi has successfully priced its offering of USD 2 billion of notes denominated in US dollars, across 2 tranches:
USD 1 billion fixed rate notes, due June 19, 2023, bearing interest at an annual rate of 3.375%,
USD 1 billion fixed rate notes, due June 19, 2028, bearing interest at an annual rate of 3.625%.
The offer was made pursuant to Sanofi’s shelf registration statement filed with the US Securities and Exchange Commission on March 15, 2016.
Sanofi intends to use the net proceeds of the offering for general corporate purposes, including the repayment of existing borrowings.
Barclays Capital Inc. and Morgan Stanley & Co. LLC acted as global coordinators for the offering. Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Morgan Stanley & Co. LLC, and MUFG Securities Americas Inc. acted as joint bookrunners for the offering.